These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30510976)

  • 1. Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity.
    Lane NE; Mohan G; Yao W; Shidara K; Lay YE; Junjing J; Dubrovsky A; Kimmel DB
    Bone Rep; 2018 Dec; 9():181-187. PubMed ID: 30510976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis.
    Mohan G; Lay EY; Berka H; Ringwood L; Kot A; Chen H; Yao W; Lane NE
    Calcif Tissue Int; 2017 Jan; 100(1):67-79. PubMed ID: 27679514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An MSC bone-homing compound, Rab001, increases bone mass and reduces the incidence of osteonecrosis in a glucocorticoid-induced osteonecrosis mouse model.
    Jiang M; Liu L; Xiang X; Liang R; Qin X; Zhao J; Wei Q
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):770-781. PubMed ID: 33319413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation.
    Jiang M; Liu L; Liu R; Lam KS; Lane NE; Yao W
    BMC Pharmacol Toxicol; 2020 Nov; 21(1):76. PubMed ID: 33187558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.
    Yao W; Lay YE; Kot A; Liu R; Zhang H; Chen H; Lam K; Lane NE
    Stem Cells; 2016 Oct; 34(10):2587-2600. PubMed ID: 27334693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains.
    Shidara K; Mohan G; Evan Lay YA; Jepsen KJ; Yao W; Lane NE
    J Orthop Translat; 2019 Jan; 16():91-101. PubMed ID: 30723686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a mouse model of ischemic osteonecrosis.
    Kamiya N; Yamaguchi R; Aruwajoye O; Adapala NS; Kim HK
    Clin Orthop Relat Res; 2015 Apr; 473(4):1486-98. PubMed ID: 25666143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1-34) and hPTH(1-84) in the distal femur metaphyses of young mice.
    Stanislaus D; Devanarayan V; Hock JM
    Bone; 2000 Dec; 27(6):819-26. PubMed ID: 11113393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Chandler H; Brooks DJ; Hattersley G; Bouxsein ML; Lanske B
    Osteoporos Int; 2019 Aug; 30(8):1607-1616. PubMed ID: 31053927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
    Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
    Duan Y; De Luca V; Seeman E
    J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Strength/Bone Mass Discrepancy in Glucocorticoid-Treated Adult Mice.
    Dubrovsky AM; Nyman JS; Uppuganti S; Chmiel KJ; Kimmel DB; Lane NE
    JBMR Plus; 2021 Mar; 5(3):e10443. PubMed ID: 33778319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice.
    Iida-Klein A; Hughes C; Lu SS; Moreno A; Shen V; Dempster DW; Cosman F; Lindsay R
    J Bone Miner Res; 2006 Feb; 21(2):274-82. PubMed ID: 16418783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats.
    Okimoto N; Tsurukami H; Okazaki Y; Nishida S; Sakai A; Ohnishi H; Hori M; Yasukawa K; Nakamura T
    Bone; 1998 May; 22(5):523-31. PubMed ID: 9600787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats.
    Arita S; Ikeda S; Sakai A; Okimoto N; Akahoshi S; Nagashima M; Nishida A; Ito M; Nakamura T
    J Bone Miner Metab; 2004; 22(6):530-40. PubMed ID: 15490262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).
    Mosekilde L; Søgaard CH; Danielsen CC; Tørring O
    Endocrinology; 1991 Jul; 129(1):421-8. PubMed ID: 2055197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.